Literature DB >> 7630926

5-Hydroxytryptamine pathways in anxiety and its treatment.

S L Handley1.   

Abstract

The effects of manipulating 5-hydroxytryptamine (5HT) neuronal function in humans and in animals are reviewed. 5HT pathways do not have a unitary function in modulating anxiety. It is proposed that, rather than acting as input or output channels for brain aversive systems, these pathways provide information concerning waking/motor status, which is crucial to the organisation of appropriate responses to threat. Each terminal region can make use of this information in different ways. Globally, the influence of 5HT neurones on higher centres appears predominantly to facilitate information processing relevant to threat, while their major influence on brainstem centres may be a restraining one.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7630926     DOI: 10.1016/0163-7258(95)00004-z

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  23 in total

1.  Low doses of 8-OH-DPAT prevent the impairment of spatial learning caused by intrahippocampal scopolamine through 5-HT(1A) receptors in the dorsal raphe.

Authors:  M Carli; C Balducci; R Samanin
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

Review 2.  Triple reuptake inhibitors as potential next-generation antidepressants: a new hope?

Authors:  Horrick Sharma; Soumava Santra; Aloke Dutta
Journal:  Future Med Chem       Date:  2015-11-30       Impact factor: 3.808

3.  Effects of milnacipran in animal models of anxiety and memory.

Authors:  Vânia K M Moojen; Márcio Rodrigo Martins; Adalisa Reinke; Gustavo Feier; Fabiano R Agostinho; Edson M Cechin; João Quevedo
Journal:  Neurochem Res       Date:  2006-05-09       Impact factor: 3.996

4.  Brain mast cells link the immune system to anxiety-like behavior.

Authors:  Katherine M Nautiyal; Ana C Ribeiro; Donald W Pfaff; Rae Silver
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-11       Impact factor: 11.205

5.  Increased anxiety of mice lacking the serotonin1A receptor.

Authors:  C L Parks; P S Robinson; E Sibille; T Shenk; M Toth
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

6.  The loudness dependence of the auditory evoked potential (LDAEP) as a predictor of the response to escitalopram in patients with generalized anxiety disorder.

Authors:  Young-Min Park; Do-Won Kim; Sangrae Kim; Chang-Hwan Im; Seung-Hwan Lee
Journal:  Psychopharmacology (Berl)       Date:  2010-11-06       Impact factor: 4.530

7.  S 15535, a benzodioxopiperazine acting as presynaptic agonist and postsynaptic 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal scopolamine.

Authors:  M Carli; C Balducci; M J Millan; P Bonalumi; R Samanin
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

8.  Neurochemical and behavioural effects of hypidone hydrochloride (YL-0919): a novel combined selective 5-HT reuptake inhibitor and partial 5-HT1A agonist.

Authors:  Li-Ming Zhang; Xiao-Yun Wang; Nan Zhao; Yu-Lu Wang; Xiao-Xu Hu; Yu-Hua Ran; Yan-Qin Liu; You-Zhi Zhang; Ri-Fang Yang; Yun-Feng Li
Journal:  Br J Pharmacol       Date:  2017-03-21       Impact factor: 8.739

Review 9.  Serotonergic function, two-mode models of self-regulation, and vulnerability to depression: what depression has in common with impulsive aggression.

Authors:  Charles S Carver; Sheri L Johnson; Jutta Joormann
Journal:  Psychol Bull       Date:  2008-11       Impact factor: 17.737

10.  Bi-directional modulation of bed nucleus of stria terminalis neurons by 5-HT: molecular expression and functional properties of excitatory 5-HT receptor subtypes.

Authors:  J-D Guo; S E Hammack; R Hazra; L Levita; D G Rainnie
Journal:  Neuroscience       Date:  2009-09-22       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.